Atlas Trials

Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders

Clinical trial NCT01273064 · TERMINATED

Trial details

NCT number
NCT01273064
Sponsor
Conatus Pharmaceuticals Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C
Start date
2011-01-01
Primary completion
2011-09-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.